Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex appoints Dr Adam King to its regulatory team

Dr Adam King joins the German group as a senior director

Adam KingPharmaLex has appointed Dr Adam King as its senior director, regulatory affairs and service area, a role that will see him work on regulatory activities related to mergers and acquisitions.

He brings over 30 years’ experience working in the pharmaceutical industry to the Mannheim, Germany-based pharmaceutical services group. During that time he spent over 18 years in regulatory affairs, with a focus on radiopharmaceuticals, regulatory strategy development and the oversight of regulatory affairs CMC programmes.

He said: “I am excited to be part of the PharmaLex team and to spearhead a delivery service area to offer my experience for current/prospective clients in supporting the regulatory activities related to mergers and acquisitions.”

King’s most recent experiences include leading a team of regulatory consultants to complete a CMC compliance project and he has also been R&D lead for the design and implementation of an electronic document management system, publishing tools into a combined R&D and manufacturing environment.

Dr Kirsten Jacobs, executive vice president, head of global regulatory affairs at PharmaLex, said: “Adam’s appointment demonstrates our commitment to developing our existing regulatory team, helping to guide our growing customer base to regulatory milestone achievements.

“His wide-ranging experience of activities needed for M&A will provide both the UK and global team with vital skills that enable us to provide our clients with added value.”

24th August 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics